People · Operator
Named in public records as an officer, director or promoter · active 2015–2023 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CarePredict, Inc. | — | Other Technology | Series B | $38.8M | $283.5M | 2018 |
| OptMed, Inc. | — | Biotechnology | Series A | $9.7M | $7.2M | 2015 |
Sanket Parekh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sanket Parekh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Philip Gisi | 1 | 4 |
| Marc Loev | 1 | 4 |
| Dean Hatton | 1 | 4 |
| GREG MADDEN | 1 | 3 |
| Sanjay Khosla | 1 | 3 |
| Ervin Braun | 1 | 2 |
| Gregory Madden | 1 | 2 |
| Martin Sands | 1 | 2 |
| Steven Sands | 1 | 2 |
| Kevin McKim | 1 | 1 |
| Chris Winkle | 1 | 1 |
| Peter Livingston | 1 | 1 |
| Howard Schrayer | 1 | 1 |
| Jeffrey Berg | 1 | 1 |
| Martin Knopf | 1 | 1 |
| Satish Movva | 1 | 1 |
| Alain Klapholz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.